Reticular Pseudodrusen Progression Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in industrial countries. Reticular pseudodrusen (RPD) have been recognized as an additional phenotypic characteristic frequently observed in patients with AMD. Several studies have proven that the prevalence of RPD is associated with AMD as well as a high risk of disease progression to geographic atrophy, the late form of dry AMD. The pathogenesis of RPD is yet still incompletely understood. Retrospective studies have demonstrated that the RPD affected retinal area increases over time. Potential factors influencing progression of RPD have not been intensely studied and potentially predictive markers are yet unknown. The primary objective of this study is to characterize RPD progression in more detail and to identify predictive markers of RPD progression and development of AMD late stages.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Role of Macular Pigment in Patients With Age-related Macular Degeneration

NCT00494325

Age Related Maculopathy

COMPLETED

Vitamin A Palmitate Supplementation in Patients With Reticular Pseudodrusen (RPD) and Delayed Dark Adaptation

NCT03478878

Reticular Pseudodrusen (RPD) Age-Related Macular Degeneration

COMPLETED EARLY_PHASE1

The Association of the Peripheral Retinal Changes and Genotypic Changes in Patients With Age Related Macular Degeneration

NCT03492853

Peripheral Retinal Degenerations, Age Related Macular Degeneration Polymorphisms

COMPLETED

Natural History of PRPF31 Mutation-Associated Retinal Dystrophy

NCT05573984

Retinitis Pigmentosa Eye Diseases, Hereditary Retinal Dystrophies +2 more

ACTIVE_NOT_RECRUITING

Natural History Study in Patients with PDE6A-, PDE6B- and RHO-linked Retinitis Pigmentosa

NCT06323772

Retinitis Pigmentosa

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Age-related Macular Degeneration

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Informed consent
* Men and women, any race, aged 60 years or older at the baseline visit
* Presence of RPD without any other type of drusen, hypo/hyperpigmentation, geographic atrophy, choroidal neovascularization
* Patient is willing to undergo ocular examinations once every 12 for up to 24 months

Exclusion Criteria

* Presence or history of soft drusen, hypo-/hyperpigmentation, geographic atrophy or choroidal neovascularization in the study eye
* Ocular disease in the study eye that may confound assessment of the retina (e.g., diabetic retinopathy, uveitis)
* Any condition that would make adherence to the examination schedule of once every 12 months for up to 24 months difficult or unlikely, e.g., personality disorder, chronic alcoholism, Alzheimer's Disease or drug abuse

Minimum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No